R&D News | pharmaphorum

News

New malaria vaccine shows high efficacy, yields high hopes

A malaria vaccine developed by members of the University of Oxford team behind the AstraZeneca COVID-19 jab has been hailed as a possible game-changer in the fight against the deadly parasi

News

Roche takes another punt on IL-2 in cancer with Good takeove...

Despite setbacks for projects trying to harness the power of the cytokine interleukin-2 (IL-2) as a cancer therapy, there are still plenty of players on the field – and Roche has just joine

News

Pleco raises €17m for tumour microenvironment drug

Pleco Therapeutics has closed a first-round financing, raising just over €17 million that it says will fund the development of its lead therapy for acute myeloid leukaemia (AML) through to

News

Data dive could give PolyPid antibiotic a lifeline

Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections failed a phase 3 trial, although there may still be a way forward f

News

Novartis lines up Merck exec to replace R&D leader Jay Bradn...

Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D

News

AZ blocks former exec from taking up role at GSK – for now

AstraZeneca has succeeded in a last-gasp effort to stop its former head of investor relations joining rival UK pharma group GSK, after winning an injunction in the High Court in London.

New malaria vaccine shows high efficacy, yields high hopes

Roche takes another punt on IL-2 in cancer with Good takeove...

Pleco raises €17m for tumour microenvironment drug

Data dive could give PolyPid antibiotic a lifeline

Novartis lines up Merck exec to replace R&D leader Jay Bradn...

AZ blocks former exec from taking up role at GSK – for now

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks